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Coagulase negative staphylococcal (CNS) septicaemias 
are a relatively common cause of serious febrile illness 
among neonates. Often the source of the infecting 
organism is unknown. Recent work at Glasgow Dental 
School has shown the importance of staphylococci as 
members of the oral flora. This raises the possibility that 
the mouth may be a reservoir for systemic infections 
with staphylococci (Kennedy et al. J, Med. Microbial. 
2000; 49: 367-70). This study investigated the colon- 
isation of the oral cavity by staphylococci over the first 
four weeks of life, among a cohort of premature neo- 
nates, and also determined the possible source of CNS 
among a cohort of low birth weight neonates presenting 
with a CNS septicaemia. Over a three month period, all 
premature neonates born in the Royal Maternity 
Neonatal Unit were enrolled. Swabs were collected from 
the axilla, hand, foot, mouth and/or throat at birth, and 
on days 4,7,14,21 and 28 after birth. These swabs were 
cultured on blood agar and mannitol salt agar for 48 
hours at 37°C. All CNS isolates from these sites and from 
positive blood cultures were speciated using API32 
Staph. Where appropriate, typing by pulsed field gel 
electrophoresis was also employed to demonstrate strain 
relatedness between blood culture isolates and those 
from other sites in the same individual. Several clones 
were found to be endemic within the unit, infecting up 
to 31 babies over a period of at least two years. 
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Objective: Candida parapsilosis has recently emerged as 
the predominant non-albicans spp causing fungemia 
in neonates as well as clusters and common-course 
outbreaks. In contrast, Candida tropicalis fungemia has 
not been adequately described in neonates and the 
significance of gastrointestinal colonization of neonates 
by this pathogen as well as of various risk factors 
remains speculative. We performed a prospective study 
of fungal colonization and infection in the Aristotle 
University neonatal intensive care unit. 
Methods: Surveillance cultures of the mouth and peri- 
neum were performed from 12/98 to 12/99 in 593 infants. 
Potential environmental reservoirs and possible risk 
factors for the acquisition of C. tropicalis were searched. 
Results: 72 neonates were colonized by yeasts, among 
which 28 were C. albicans, 17 C. tropicalis and 5 C, 
parapsilosis. Ten cases of fungemia occurred: 6 C. 
parapsilosis, 2 C. tropical& 1 Candida glabrata and 1 
Trichosporon asahii. During the first 4 months, C. 
tropicalis caused 2 fungemias and 17 cases of colon- 
ization. All infants with C. tropicalis strains had over- 
lapping NICU stays. 2 out of 17 neonates were colonized 
by C. tropicalis at an early stage probably through vertical 
transmission. The remaining neonates were colonized at 
a late stage (>7 days) during their NICU stay suggesting 
nosocomial acquisition of C tropicalis. Colonization by 
C. tropicalis preceded in both infected neonates. 
However the fungemia/colonization ratio (2/17) was 
lower than that for C. parapsilosis (34 p=O.O5). There 
was no prophylactic use of antifungal azoles in the NICU 
and extensive environmental cultures revealed no 
common source for C. tropicalis. Only prior admini- 
stration of total parenteral nutrition was found to be 
significant risk factor for C. tropicalis colonization (com- 
parison with C. albicans, p=O.O24). All 4 courses of C. 
tropicalis fungemia were successfully treated with ampho- 
tericin B. No new cases of colonization or fungemia due 
to C tropicalis have occurred after 2000. 
Conclusions: The high prevalence of C. tropicalis 
colonization (>25%) and the emergence of that 
pathogen as cause of neonatal fungemia during our 
study suggests an outbreak in the unit. Colonizing C. 
tropicalis strains are able to cause invasive disease in 
neonates; however, their invasiveness is moderate and 
the outcome of the infection fair. 
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Microculture tetrazolium assay (MTT) was applied 
on the freshly isolated peripheral blood lymphocytes 
(PBL) of 48 head and neck cancer (HNCA) patients 
who were selected randomly and without any bias from 
two main centers; University hospital of Saddam College 
of Medicine and radiotherapy center in Baghdad, Iraq. 
In addition to that 22 apparently healthy subjects were 
used as a healthy control (HC) group for comparison 
with HNCA patients. 
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MTT assay is one of the most prevalent in vitro 
methods that has been used to test CM1 function 
by using 3-[4,5,dimethylthiazol-2-yl]-2,5diphenyl tetra- 
zolium bromide. In our study, we used the following 
mitogens; Concanavalin A as a mitogenic positive 
control, SZcomplex (Saddam College of medicine) and 
Pneumo-23 (Pasteur merieux connaught) vaccine as test 
substances, no mitogens as negative control. 
Our study has it’s own objectives for the application 
of MTI assay. The first objective was the evaluation of 
CM1 level in HNCA patients in comparison with HC 
group via the susceptibility of PBL to be stimulated by 
different mitogenic substances.The second objective was 
the evaluation of using SZcomplex and P-23 vaccine as 
a biological modifiers that could be used in the immune 
therapy of HNCA in particular and other cancers in 
general. 
It has been shown that all HNCA groups were 
immunosuppressed in comparison with HC subjects. 
Nasopharyngeal CA (NPC) patients have shown the 
lowest CM1 level, then CA larynx (CL) and finally hypo- 
pharyngeal CA patients (HPC). It is highly suggestive 
that immune suppression in NPC patients may be 
necessary to activate the latent phase of Epstein-Barr 
virus having said that 85% of NPC patients in Iraq 
caused by EBV which has been proved by another study 
that we conducted. 
The most important result of our study that it has 
been shown that both S2-complex and Pneumo-23 
vaccine were excellent immune-stimulatory agents in 
vitro, and they might be a powerful agents of the future 
immune-therapy against cancers in general and HNCA 
in particular. 
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An epidemiological case study has been conducted on 
142 different head and neck cancer (HNCA) patients in 
Iraqi population. Patients were examined at different 
stages of the disease, 8 different types of HNCA were 
covered by this study. But for statistical purposes we 
have taken only the 3 most common types of HNCA 
for conducting our comparative epidemiological study 
which were nasopharyngeal CA (NPC), CA larynx (CL), 
and hypopharyngeal CA (HPC). NPC group was our 
top interest due to the fact that it is largely caused by 
viral infection, Epstein Barr virus (EBV) in that EBV- 
caused NPC is not uncommon event in the middle east 
and this unique etiology makes NPC an interested group 
of HNCA. Epidemiological parameters taken were age, 
sex, histology of the disease, staging, smoking, alcohol 
intake. It has been found that each HNCA group has it’s 
own profile of risk factors, but some of risk factors were 
pan-affective for all HNCA groups. 
It has been shown that all HNCA patients of 
squamous cell carcinoma (SCC) except for NPC patients 
that have elicited a relatively large proportion of highly 
undifferentiated carcinoma, namely lymphoepithelioma 
(LE). The age of HNCA patients was ranging between 
16 to 74 years old and found that age in HNCA patients 
is not distinct for each type of HNCA and these differ- 
ences are due to chance factor. 
It has been shown that the sex ratio in HNCA patients 
is different from each other significantly (p<O.O05). In 
general male:female ratio was 2.6:1 and there was a 
clear male predominance in HNCA patients over 
females except in HPC patients. Also it was found that 
smoking is a very important risk factor for HNCA, 
especially for NPC group. Regarding alcohol intake it 
was found that HNCA patients in general not so largely 
affected by this factor except for NPC patients who 
have shown a great relation with the level of daily 
alcohol intake. Lastly, all HNCA groups have shown a 
good relation with the positive family history but this 
feature was poor in case of NPC patients which is 
may be due to fact that NPC is largely caused by 
environmental factors rather than inherited ones like 
EBV as viral etiological factor. 
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The antimicrobial activity of ertapenem, a new long- 
acting carbapenem which can be dosed once daily, 
was tested against aerobic gram negative bacilli isolated 
from blood stream infections (BSI) in 156 cancer patients 
during the years 2000 and 2001. The MICs were deter- 
mined by NCCLS approved microdilution methods. The 
bacteria tested included 44 Klebsiella spp., 42 Escherichia 
coli, 19 Pseudomonas aeruginosa, 18 Enterobacter spp., 9 
Acinetobacter baumannii, 8 Citrobacter freundii, 5 
Proteus mirabilis, 4 Serratia marcescens, 3 Stenotropho- 
monas maltophilia, 2 Salmonella spp., and 2 Pantoea 
agglomerans. 
Ertapenem inhibited 75%, 80% and 83% of all 
isolates at concentrations of 1 pg/ml, 2 pg/ml and 4 
kg/ml respectively (breakpoint for susceptibility 58 
kg/ml). Ertapenem exhibited good activity against 
Klebsiella (MICgo <0.0625), E. coli (MI&, ~0.0625) 
Enterobacter (MIC90 0.5), Citrobacter (MICgo 52 
kg/ml), Proteus (MIC9o 0.125) Serratia (MTC90 0.0625) 
